Table 3.
Hematological parameters on day 3
| Variable | All patients (n ± 129) | Survivors at day 28 (n ± 58) | Nonsurvivors at day 28 (n ± 71) | Significance |
|---|---|---|---|---|
| Hemoglobin (g/dL) | 9.42 ± 1.95 | 9.52 ± 2.01 | 9.31 ± 1.91 | 0.56 |
| Hematocrit (%) | 29.09 ± 6.22 | 29.06 ± 6.29 | 29.13 ± 6.20 | 0.94 |
| Mean cell volume (fL) | 91.09 ± 20.47 | 92.36 ± 28.31 | 89.86 ± 7.36 | 0.51 |
| Mean cell hemoglobin (g/dL) | 27.02 ± 3.04 | 26.73 ± 3.05 | 27.03 ± 3.03 | 0.31 |
| Red cell count (106/µL) | 3.2 (2.87–3.74) | 3.43 (3.08–3.74) | 3.13 (2.7–3.7) | 0.17 |
| Red cell distribution width (%) | 16.8 (15.1–20.1) | 16.45 (15.1–19.0) | 17.2 (15.1–21.4) | 0.30 |
| Total leukocyte count (103/dL) | 12.3 (8.69–18.30) | 12.64(10.5–15.90) | 10.1 (7.17–18.33) | 0.33 |
| Differential leukocyte count (%) Neutrophil Lymphocyte Monocyte Basophil Eosinophil |
80.56 ± 13.14 11.29 ± 9.04 5.99 ± 5.32 0.32 ± 1.06 1.01 ± 1.73 |
79.1 ± 13.86 11.79 ± 7.29 5.73 ± 4.04 0.45 ± 1.35 1.45 ± 1.86 |
81.98 ± 12.36 10.80 ± 10.49 6.24 ± 6.33 0.20 ± 0.66 0.60 ± 1.50 |
0.23 0.55 0.60 0.20 0.00 |
| Absolute leukocyte count (cells/dL) Neutrophils Lymphocytes Monocytes Basophils Eosinophils |
10428.55 (6615–15732) 1117.3 (507–1855.9) 571.95 (314.75–929.25) 0 (0–28.9) 32.85 (0–126.5) |
10428.55 (7592.4–13436.8) 1504.2 (858–1992.6) 666 (413.4–929.25) 13.55 (0–46) 98.35 (14–292) |
10131.35 (5216.26–16683.44) 672.33 (329.34–1574.75) 516.1 (288.5–914.25) 0 (0–15.03) 18.76 (0–65.4) |
0.61 0.001 0.20 0.03 0.001 |
| Platelet (103/dL) | 129 (80–223) | 151 (90–262) | 120 (56–188) | 0.05 |
| Platelet distribution width (%) | 16.1 (14.2–18.0) | 16.1 (14.2–17.5) | 16.35 (14.15–18.2) | 0.67 |
| Neutrophil–lymphocyte ratio | 14.74 ± 15.15 | 10.72 ± 10.30 | 18.62 ± 17.94 | 0.004 |
| Platelet–lymphocyte ratio | 29.68 ± 38.63 | 22.54 ± 20.42 | 36.60 ± 49.58 | 0.04 |
| Delta red cell distribution width (%) | −5.11 ± 55.40 | −10.46 ± 79.36 | −0.02 ± 0.17 | 0.30 |
| Delta platelet distribution width (%) | −0.00 ± 0.12 | 0.00 ± 0.12 | −0.00 ± 0.12 | 0.62 |